Introduction

The natural purpose of the female human breast is to provide sustenance and nourishment to babies.  While almost all transsexual women proudly regard their breasts as an important sign of their femininity and womanhood, few really consider their biological purpose.

Father and mother, Lisa-Anne had SRS three months after conceiving daughter Michelle with her former wife.

Some years ago an English newspaper published a story about a young woman breast-feeding her baby in a restaurant, she was asked to leave and wasn't at all happy about that.  Not really headline material, but readers then discovered that the woman in question was a male-to-female transsexual.  As a 'husband', she had begun female hormone treatment at about the same time as his/her wife had become pregnant.  After the baby's birth, the transwoman had acupuncture to help kick-in her own milk production and was sharing nursing duties with her former wife.  The story was inevitably intended to be rather sensationalist, but some transsexual women reading it were probably surprised to learn that their breasts might be capable of performing the function that they were intended for by nature.

The breasts of a transsexual woman are in fact quite capable of producing milk ("lactation") given the following circumstances:

1. The breast has not been badly damaged internally, e.g. by breast augmentation implants
2. The breast has a sufficiently well-developed internal structure
3. There are suitable stimuli (physical, hormonal, psychological) to start and then maintain the production of milk
4. There's a functional pituitary gland [Closely linked with point 3]
5. The woman is in reasonably good health - a sick or very poorly fed body won't waste energy and nutrition producing milk.

Motivation
Inducing lactation is not easy; it will often take a lot of time and a lot of effort over a long period.  The necessary motivation is essential or failure is almost inevitable.

One study of 27 genetic women who undertook a lactation induction programme found that 24 (89 percent) were successfully breast feeding well-nourished children.  All 11 women who had never previously lactated were successful.  

Whilst quite such a high success rate cannot be achieved with male-to-female transsexual women, there's no doubt that given a high degree of motivation combined with medication, support, and encouragement; lactation induction can often be successful in transsexual women.

Breast Augmentation

A majority of transsexual women have had breast augmentation (implants), but the chances are good that the implants in themselves will not prevent lactation.  Studies show that only about 10% of genetic XX woman with implants are unable to breast feed due to damage to their breasts caused by the implants.  However, unfortunately many TS women have small and underdeveloped (hypoplastic) breasts prior to breast augmentation surgery.  Although breast augmentation will greatly improve the external appearance of such breasts, even giving the impression of fully developed breasts, it does not solve the underlying milk supply problem due to insufficient internal development, and it will thus still be difficult for the woman to produce milk and nurse.

A transsexual woman expressing.  Note the periareolar incision scars from breast augmentation.

With a breast that has been surgically enlarged with implants, the nipple may be more or less sensitive than normal.  If the nerves around the areola were not cut or damaged during the surgery then it should still be possible to nurse fully or partially.  Nerves are vital to breastfeeding since they trigger the brain to release prolactin and oxytocin, two hormones that affect milk production.  The chances of breastfeeding also improve if the milk duct system is intact.  It's impossible to know the full extent of damage — if any — until a woman tries to make and express milk.  Once lactation starts, implants may also cause exaggerated breast engorgement with more intense than normal pain, fever, and chills.

The likelihood that implants cause serious lactation and milk production problems depends directly upon the kind of surgery had.  Incisions that were made under the fold of the breast (inframammary) or through the armpit (transaxillary ) shouldn't cause any trouble.  However, the popular periareolar method, making a "smile" incision around the areola, has greater risk of problems.

There's absolutely no evidence that silicone from silicone implants leaks into breast milk, but even if it did, it probably wouldn't harm a baby.  Silicone is very similar to a substance used to treat a baby's stomach gas.

Breast Development

In order to be able to produce milk internally the breast must have certain structures in place, but fortunately these are present at birth in every human, whether genetically male or female.   It's also worth noting that highly visible factors such as breast size and areola diameter that are often of great importance to transsexual women in fact have relatively little effect on the breasts potential ability to lactate and the quantity and quality of the milk that will be produced.  Whatever the size of her breasts, a M2F transsexual woman can still potentially breastfeed if the internal structures are in place and undamaged.

Structure of the Female Breast

Stages of Mammary Development
At birth the rudiments of the functional mammary gland are in place: the nipple and areola are formed along with a rudimentary system of mammary ducts extending into a small fat pad on the chest wall.   The mammary gland remains a rudimentary system of small ducts until puberty when the advent of oestrogen secretion by the ovaries brings about the first stage of the four stages of mammary development: mammogenesis, lactogenesis, lactation and involution.

Mammogenesis commences at puberty with the onset of oestrogen secretion by the ovaries, usually between the ages of 10 and 12 in the girl.  Oestrogen causes enlargement of the mammary fat pad, one of the most oestrogen-sensitive tissues in the human body, as well as lengthening and branching of the mammary ducts.  About 40% of male children also initiate mammary development during puberty due to the tendency of the testis to secrete significant quantities of oestrogens in early phases of its development.  As testosterone secretion increases this function is lost.

Oestrogen stimulates breast growth by acting on the mammary tissue.   With the onset of the menstrual cycle the presence of progesterone stimulates the partial development of mammary alveoli, so that by the age of 20 the mammary gland in the woman who has not been pregnant consists of a fat pad through which course 10 to 15 long branching ducts, terminating in grape-like bunches of mammary alveoli.  In the absence of pregnancy the gland maintains this structure until menopause.

Mammogenesis is completed during pregnancy, with the gland becoming able to secrete milk sometime after mid-pregnancy.  

Lactogenesis (referred to as the time when the milk "comes in") starts about 40 hours after birth of the infant and is largely complete within five days. 

When nursing has ceased the gland undergoes partial involution, losing many of its milk producing cells and structures, a process which is only completed after menopause. 

Breast Development in the Transsexual Woman
A combination of supportive tissue, milk glands, and protective fat makes up a large portion of every woman's breasts (or mammary glands).  Every person is born with milk ducts — a network of canals that transport milk through the breasts — present from birth.  In the male-to-female transsexual woman the mammary glands stay quiet until commencing female hormone treatment releases a flood of oestrogens in the body in what's effectively a female puberty - thus initiating the first phase of mammogenesis and causing the breasts to grow and swell.

The amount of hormone induced breast development achieved in the genetically XY male transsexual woman is very age dependent.  Young boy-to-girls who start female treatment during their normal puberty years (i.e. about age 12-16) are likely to reach near normal breast development.  But unfortunately the amount of development that can be expected rapidly tails off as the age of the commencement of hormone increases, and older transsexual women will commonly suffer from underdeveloped (hypoplastic) breasts. 

Breast development is categorised by the "Tanner Stages" scale which goes from I to V.  It can again be emphasized that there is really NO minimum degree of breast development in order to be able to lactate; there are well documented instances of even men with minimal Tanner I breasts producing some milk and breast feeding without using hormones.  On the other hand there is no doubt that the higher the development stage, the easier it will usually be to start lactation and the greater the likely quantity of milk produced.  In general, well developed Tanner IV or V type breasts are really required for successful nursing of a baby, perhaps a majority of the girls who start hormone treatment by age 25 are likely to achieve this but most older woman will achieve no more than Tanner III or even II breast development.  Such hypoplastic breasts are very small or narrow, lack normal fullness, and may seem bulbous or swollen at the tip.  They are also likely to be widely spaced and one breast may be larger than the other.  Hypoplastic breasts don't develop and grow in response to any additional hormones given in order to simulate pregnancy and prepare the breast for lactation.  Breasts of this kind have fewer milk glands than normal, leading to milk-production problems.  

Breast Development During Pregnancy

It is necessary to understand how the human breast develops and prepares for milk production during a woman's pregnancy.  

Mammogenesis is completed during pregnancy - indeed pregnancy is the period of greatest mammary growth.  Extensive lobular and alveolar development occurs only during pregnancy, also milk secretory cells only develop during pregnancy, therefore this period is extremely important in determining the number of secretory cells in the lactating gland and the subsequent production of milk.  Mammary growth (of the mother) accelerates throughout pregnancy and is fastest during the later stages of pregnancy, which coincides with the most rapid period of foetal growth. 

Breast Structure of a Pregnant Woman
A pregnant woman will certainly notice a huge metamorphosis occurring in her bra cups. These physical changes include:

• tender, swollen breasts
• darkened nipples and areolas (the circle of skin surrounding the nipple)
• the appearance of tiny bumps around the areola called the Glands of Montgomery

But perhaps even more remarkable than this visible transformation are the extensive changes taking place inside her breasts, primarily under the stimulation of high levels of oestrogen and progesterone, combined with the rising levels of prolactin from the pituitary and human placental lactogen (HPL) from the placenta. 

Progesterone and Oestrogen blood plasma levels rise steadily during pregnancy.

Nestled amid the breasts fat cells and glandular tissue is an intricate network of channels or canals called milk ducts.  The additional hormones released during pregnancy cause the cells of the mammary fat pad to diminish in size and their place is taken by the developing ducts and alveoli. 

Milk is produced inside the alveoli, which are surrounded by tiny muscles that squeeze the glands and push milk out into the ductules.  Those ductules lead to a bigger duct that widens into a milk pool or milk sinus directly beneath the areola.  Milk pools (also known as sinus) act as reservoirs that hold milk until a baby suckles it through tiny openings in the nipple.   Essentially the 15 or 20 milk ducts act as individual straws that all end at the tip of the nipple and deliver milk into a baby's mouth. 

The mammary gland becomes able to secrete milk sometime after mid-pregnancy, and begins to produce small amounts of a protein- and fat-rich secretion sometimes referred to as precolostrum.  It seems likely that mammary development continues through the duration of pregnancy since milk secretion by mothers of premature infants often appears to be diminished.  The onset of copious milk secretion (or lactogenesis) is held in check by the high levels of circulating progesterone until after child birth. 

A woman's breasts enlarge and the areolas become darker
and more prominent during pregnancy

Differentiation of the breast to its mature status occurs by the third month of pregnancy, although it will take about 6 months for the breast system to fully develop and become functional for lactation.  Indeed, mammary growth will continue right up to birth, and even after if nursing.  In a pregnant woman, by time the baby is born, glandular tissue has replaced most of the fat cells and accounts for the much enlarged breast.  The increase in size varies greatly with the individual, ranging from zero to 800 cc of volume (and 1½ lb of weight!) per breast; the average being about 400 cc.  It is normal for women to increase by one or two cup sizes during pregnancy, although this will decline (sometimes dramatically) after the cessation of lactation.

Oestrogen and Progesterone
Optimal mammary growth requires both oestrogen and progesterone hormones.  Together, these result in growth of the lobular and alveolar system.  Both hormones are elevated during pregnancy, which is why there is no such "lobuloalveolar" growth during a woman's oestrus (fertility) cycle, when only one of these hormones is elevated at a time.  Progesterone is elevated throughout gestation (required for maintenance of pregnancy), while oestrogen is particularly elevated during the second half of gestation.  Consequently, most of the mammary growth during the first half of gestation is mainly ductal growth and lobular formation.  In the second half of gestation, ductal growth continues, but most growth is lobuloalveolar.

Oestrogen and progesterone together establish the conditions needed for geometric cell multiplication to occur. For example, from one original cell, 8 cell divisions yields 128 cells.

During pregnancy, the mammary tissue has oestrogen receptors and progesterone receptors. During lactation the mammary gland has oestrogen receptors, but not progesterone receptors.

Other hormones
As well as the oestrogen and progesterone hormones well known to transsexual women, there are several other hormones important to breast development and milk production.  Indeed, mammary development in the pregnant woman takes place under the influence of an extraordinarily complex mix of hormones, including:-  prolactin, human placental lactogen, estradiol (a type of oestrogen), progesterone, insulin, cortisol, growth hormone, thyroid hormones ...

Prolactin is a protein hormone secreted from the anterior pituitary gland, as well as assisting in breast development; it stimulates and controls the actual production of milk. 

In a pregnant woman, the placenta produces an important hormone called Human Placental Lactogen (HPL) which adjusts the maternal metabolism.  One of its functions is similar to prolactin, i.e. stimulation of milk production by the mammary glands.  HPL seems to work with oestrogen and progesterone to increase the number of alveoli in mammary glands and also plays a role in making the alveoli functional (capable of producing milk).  It's thought that the level of HPL hormone activity in the maternal blood regulates the extent of mammary development during late pregnancy.  HPL also causes the secretion of a form of milk called colostrum from about the fifth month of pregnancy. 

Yet another, and apparently unimportant, hormone is secreted by the pituitary gland of a pregnant woman, Melanocyte Stimulating Hormone (MSH).  Its only known effect is to stimulate the skin to produce pigmentation, causing the aeroli to enlarge and darken. 

Milk Production in a Maternal Mother

Lactogenesis
In a human mother lactogenesis, or the onset of copious milk secretion, (also referred to as the time when the milk "comes in") starts about 40-48 hours after child birth and is largely complete within five days.  Milk secreted during the period between colostrum secretion and mature milk is called transition milk.  

Lactogenesis is associated with an abrupt increase in milk volume secretion, which goes from a mean of about 50 ml per day on day 2 of lactation to about 500 ml per day on day 4.  After this time there is a gradual volume increase to about 850 ml/day by three months postpartum. There are also profound changes in milk composition during the early post child birth period as the production of milk products comes into high gear.  By 10 days after child birth the milk has assumed the composition characteristic of mature milk. There are minor composition changes that continue throughout lactation.  Full lactation, or the secretion of mature milk, continues as long as the demand is there, up to three to four years for infants in some cultures.

Three factors are necessary for successful lactogenesis: a developed mammary gland, continued high plasma prolactin levels, and a fall in progesterone and oestrogen levels that otherwise inhibit lactation - it can therefore be partially inhibited by high doses of oestrogen.  It is important to note that the milk "comes in" at the same rate whether the infant suckles during the first 48 hours or not.  Thus the onset of milk secretion depends, not on milk removal from the breast, but on the changes in hormonal status associated with child birth.  However, continued milk secretion depends on milk removal from the breast, the involutional process sets in after only 3 to 4 days if breast-feeding is not initiated.

Breast Stimulation in the Transsexual Woman

Hormonal Stimulation
Lacking the hormone producing ovaries and placenta present in a pregnant woman, the transsexual woman attempting to induce lactation must take oestrogen by some artificial means (oral, injection, patches, etc.).  The oestrogen is then abruptly withdrawn to mimic the rapid hormonal changes following delivery. 

It is appropriate at this point to distinguish between trying to achieve some slight lactation, ranging from a few drops up to as much as 35% that of a nursing mother, and trying to achieve full and copious milk production as the primary sorice of nutrient for a baby.  Both require some degree of hormonal stimulation, but it's a case of for how long, and also how well the breasts respond to the hormonal stimulation.

If only a minimal degree of lactation is being attempted then the high oestrogen regimen may be as short as two weeks.  But if full lactation is desired, then the transsexual woman must try to induce all the necessary developmental changes in her breasts by simulating a full period pregnancy by taking high doses of oestrogen and progesterone hormones for a period of at least six months (probably not coincidently, a premature baby born after the 28th week or sixth month of pregnancy is "viable" and will often survive, and will thus require feeding).  This sustained hormone treatment may stimulate her breast in to developing and preparing for lactation, but unfortunately transsexual women with underdeveloped hypoplastic breasts are unlikely to succeed in this endeavour as their breasts will fail to respond to the additional hormones.

Also, in a pregnant woman her production of the estriol type of oestrogen greatly increases and it becomes the dominant type of oestrogen in her body.  When present in high levels (unlike the non-pregnant lower levels), one of its effects is to help prepare the breast for milk production.  However, the "weak" estriol oestrogen is rarely taken by transsexual women as part of their hormone therapy, instead standard oestrogen prescriptions are either of the estradiol (e.g. the Estrace brand) or estrone (e.g. the popular Premarin brand) types.  Unfortunately, prolonged taking of large doses of these "strong" oestrogen types, as is common with transsexual women, seems to de-sensitise the body to estriol, making stimulating the breast to prepare for lactation via hormones much more difficult.

Assuming that the hormones have an effect, the period of the most visible breast growth is often during the first eight weeks of treatment.  This enlargement is potentially just temporary as it's primarily due to engorgement of the blood vessels, enabling increased circulation to the breasts.  Thereafter, oestrogen hormones stimulate cell mitosis and growth of the ductal system, the development and differentiation of the glandular tissue (lobules and alveoli) is dependent on progesterone, whilst breast fat accretion seems to require both. 

Regarding other hormones found in pregnant woman:

• Prolactin may be produced naturally by the woman's pituitary gland which is helpful but probably insufficient.  Currently, there is no prolactin medication on the market but prolactin-inducing drugs are readily available and these can be taken to increase  prolactin production to normal levels. 
• HPL is valuable aid to breast development and lactation, but it's not naturally produced in the body of a transsexual woman.  Highly purified HPL is available as a medication but unfortunately it's hard to obtain, very expensive (a course would cost several hundred dollars a day), and is very rarely used as a medication.
• MSH is not believed to be necessary for lactation and is unlikely to be present in a transsexual woman.

Hand-pumps are a very cheap mechanical aid to help stimulate lactation, but they are not suitable for prolonged heavy use.

Mechanical Stimulation
If it not possible to take additional female hormones in order to stimulate the breasts in to preparing for lactation, or if (as is commonly the case) the hormones have no effect due to hyperplasic breasts, all is still not lost.  This is because prolactin and oxytocin, the hormones which govern lactation, are pituitary, not ovarian (or "female") hormones.  Both prolactin, the milk-making hormone, and oxytocin, the milk-releasing hormone, are produced in response to nipple stimulation. 

Most genetic women and some men can induce lactation to some extent with only mechanical stimulation.  This consists of breast massage, nipple manipulation, and sucking - the later either by a baby or by expressing using a good quality electric breast pump with a double pump kit.  Realistically expression by hand, or even with a hand pump, is simply not a practical alternative to an electric double breast pump given the frequent and prolonged sucking required on each breast.

A possible expressing regime: Begin by expressing each breast for about five minutes, three times a day.  Increase the length of the pumping session as you become more comfortable, until you are expressing for a total of about 15 to 20 minutes on each breast every two to three hours during the day.  Expressing both breasts simultaneously by double-pumping obviously saves a lot of time every day by this point!  You must include night time pumping sessions, allowing just one long 4-5 hours period of sleep.

Stress, tension, and fatigue all produce hormones that can reduce let-down.  Avoid smoking and excessive alcohol and caffeine - these are known to inhibit a mother's milk production and let-down. 

In order to pump effectively and increase milk supply it is essential to relax and stimulate as much as possible the milk let-down response crucial to milk expression.  Suitable mental or environmental stimuli such as baby photo's, imagining yourself breast feeding, direct sucking stimulation of the nipples and immediately surrounding tissue, playing a tape of the cries of a hungry baby, ... etc,  are essential aids to milk production.  And a partner can greatly assist with sexually arousing mental stimulation and manual manipulation of the woman's body before, and even during, her expression period.

Here are some tips to help both manual and mechanical expression:

1. Set up a regular milk expression schedule.
2. Allow enough time so you don't feel rushed.
3. Relax for 15 minutes before expressing, watch TV, listen to music, enjoy the occasional glass of wine.
4. Try to minimize distractions - take the phone off the hook, etc.
5. Try to express milk in a familiar and comfortable setting - privacy and comfortable seating promotes relaxation, which enhances let-down.
6. Follow a pre-expression routine: Use warmth to relax and stimulate milk flow by applying a warm compress to your breasts for 5 minutes or putting a warm wrap around your shoulders; relax with deep breathing and visualizations.
7. Encourage milk let-down by using an oxytocin nasal spray 2 or 3 minutes before using the breast pump - costly but worth it.
8. Think about babies - look at pictures of a baby and imagine him at your breast while you are expressing your milk.  Play a tape of a hungry baby.
9. Before pumping stimulate your breasts and nipples through massage as illustrated right.  
10. While pumping help "push" the milk towards the nipple - place your thumb opposite the fingers on either side of the areola (positioned as the pump allows), then rhythmically press your hand in towards your chest, gently squeezing the thumb and forefinger together.  Rotate the fingers to get all the milk ducts.  With practice you can do both breasts simultaneously.
11. Interrupt your pumping several times to pause and massage your breasts more.

Achieving Milk Production in the Transsexual Woman

Lactogenesis
A genetic woman who's given birth also expels the hormone-producing placenta, and the oestrogen and progesterone levels in her body suddenly drop.   In a transsexual woman, ceasing an additional high oestrogen and progesterone dosage that's been taken for several months will have the same affect if the hormones have worked.  Recognising that the "birth" has happened, the pituitary gland now signals the body to make lots of milk in order to nourish the baby by increasing its output of the hormone prolactin, and the changes in hormone levels thus cause milk production to begin.  [Studies show that prolactin make a woman feel more "motherly", which is why some experts call it the mothering hormone!]  

At this point mechanical breast stimulation, particularly sucking (with a breast pump or by a baby) should be started and an oxytocin nasal spray used to stimulate milk release.  If not already begun a course of a prolactin enhancing drug such as domperidone (brand name Motilium) is highly recommended to help milk production.  [Although the US Federal Drug Administration warns against using the anti-nausea drug for this purpose.]

Success is not guaranteed, but some milk production can be expected in a majority of cases.  Milk production typically begins between 1-4 weeks after initiating stimulation using prolactin enhancing drugs, although it can be as little as 2-3 days if hormones were taken and were effective, or as long as 4-6 weeks if relying purely on mechanical stimulation.  

One study of induced lactation using enhancing medications describes the onset of milk production being between 5-13 days.  At first, the woman may see only drops.  During the time that milk production is building, women may notice changes in the colour of the nipples and areolar tissue.  Breasts may become tender and fuller.  Some women report increased thirst, and changes in their menstrual cycle or libido.

As the body readies itself for lactation, it pumps extra blood into the alveoli, making the breasts firm and full.  Swollen blood vessels, combined with an abundance of milk, may make the breasts temporarily painful and engorged, but nursing or expressing frequently in the first few days will help relieve any discomfort.
 

Milk Release
Obviously the best and most natural way to enhance let-down is by nursing a baby.  As a baby sucks a nipple they stimulate the nursing mother's pituitary gland to release oxytocin (as well as prolactin) into her bloodstream.  If a baby is not handy, the let-down reflex can also be encouraged by using an oxytocin nasal spray such as Syntocinon which can be prescribed by a doctor.

 

Using a SNS

Nutritional Value of Induced Milk

Milk released by a mother during the first few days of lactation after giving birth is called colostrum; it is richer in proteins, minerals, and immunoglobulins and is lower in calories and fat than the mature milk that develops over the following few weeks.  The level of fats, lactose, and B vitamins gradually increases in breast milk during the first month of lactation.  Mature breast milk is rich in the mother's white blood cells and hormones and substances such as immunoglobulins, which protect the infant against bacteria and other infectious agents.

The milk brought in by inducement skips the colostral phase, instead it more closely resembles transitional and mature breast milk.  It is thus not ideal for new-born babies, but studies of non-maternal women nursing after induced lactation indicate that that their infants are well-nourished.  However, it must be noted that many women felt they were only providing about 50-70% of the nutrition their babies needed with breast milk alone.   If a transsexual woman is nursing it is therefore also very likely that she will be able to produce only a portion of the breast milk the baby needs, and it will be necessary to boost the baby's milk intake with formula.   For this a Supplemental Nursing System (SNS) is valuable alternative to the traditional bottle.  The device consists of a plastic pouch to hold breast milk or formula and attached thin, flexible tubes that run down each breast to the nipple.  Since the baby takes both nipple and tube into his mouth when he suckles, he benefits from all the breast milk that is available.

Emily feeding baby Dante using a SNS - her exhausted appearance will be familiar to many mothers!    Jane feeding Bela using a SNS Diane and new born son A lovely photo of mother Dianne and father Fernando, with baby.

Breast Feeding by Transwomen

The number of transwomen adopting babies, or having a baby via a surrogate mother other or complex arrangement is increasingly dramatically.  In some instances the transwoman is technically the baby's father as her sperm was used to impregnate an egg.

There are now numerous cases where a baby's 'mother' from its birth is a transwomen. Many want to breast feed, but can't.   However a close approximation to breast feeding - for both the baby and the mother - can be achieved using a Supplemental Nursing System (SNS).

Three examples:

• Male-to-female transwoman Emily began female hormones age 16 and was awaiting a sex-reassignment surgery when her transman partner Cai unexpectedly had a baby. Emily is genetically the father, but has been the mother since birth.  She breast-fed baby Dante with the aid of formula and a special attachment.

• Tabea unexpectedly became pregnant as her partner Jane (named changed) transitioned from male-to-female.  Jane shared feeding duties for baby Bela using a SNS and milk expressed by Tabea with a breast pump.

• Diane Rodriguez transitioned age 18, but she still hadn't had sex-reassignment surgery when her transman partner Fernando Machado had a baby.  Dianne, now age 33, shared feeding duties using formula milk with her partner and is the "mother".  The couple later had a second child.   

Achieving lactation is a challenge for MTF transsexuals (do you early want to wake up at 3:00 am to use a breast pump?), but it is quite possible as indicated at the start of this article for a transwoman to breast feed a baby.  

Christine with one of the twins for which she is technically the father, but as a mother was able to breastfeed.

In 2010 the Oprah Winfrey programme featured Dr Christine McGinn - the "Mum who fathered who own children".  Christine is a lesbian MTF transsexual woman, before SRS she had a sperm sample frozen and this was used for an IVF procedure which happily resulted in her female partner giving birth to twins.  Christine was able to breastfeed to the babies, she says:

In January 2018 Transgender Health published a case study by Zil Goldstein, and Dr. Tamar Reisman of the Mount Sinai Center for Transgender Medicine and Surgery in New York.  This describes how a 30-year old transgender woman approached Reisman and Goldstein at their clinic - "the woman was pleasant, well-nourished, and her breasts were well-developed".  They learnt that her partner was pregnant but didn't want to breastfeed, and that she was hoping to take on the role.  The clinic then conducted probably the first professionally supervised medical study in to induced lactation in a transgender woman.  The unnamed patient was able to achieve sufficient breast milk volume to be the sole source of nourishment for her child for 6 weeks after birth.  Her treatment essentially followed the basic framework already described for induced lactation:

1. An initial increase in estradiol and progesterone doses to mimic the high levels seen during pregnancy

2. The prescription of domperidone to increase prolactin levels and encourage lactation

3. The use of a breast pump to stimulate lactation

4. An abrupt reduction in estradiol and progesterone levels, with the intention of mimicking delivery.

Breast pumping and drugs best summarises the pre-requisites for lactation in a transwoman.  The smile soon fades to boredom and nausea from all the drugs.

Key points of the study include:

• The transwoman had already been on feminizing hormone therapy for six years.  At the time of her first visit to the clinic she was taking daily 50mg spironolactone, 2mg estradiol, and 100mg progesterone

• During her first visit to the clinic her breasts were evaluated as being Tanner V, i.e. fully developed.  [This is rare for a transwomen of any age]

• Treatment began with the transwoman taking domperidone 10 mg daily and using a breast pump for 5 min per breast daily

• After one month the hormone regime was increased - the domperidone dose to 20 mg, progesterone to 200 mg and estradiol to 8 mg daily.  Breast pump use increased to six times daily. Droplets of milk were starting to be produced

• After two months progesterone was increased further to 400 mg daily and estradiol to 12 mg daily.

• After three months (2 weeks before the baby’s due date) the breast pump was already collecting about 8 oz of breast milk per day. The woman's estradiol regimen was shifted to a low dose patch (0.025 mg daily) and her progesterone dose was lowered to 100 mg daily.

• At three and a half months the baby was born.  She was breastfed exclusively by the transwoman for the next six weeks. During that time the child’s pediatrician reported that the child’s growth, feeding, and bowel habits were developmentally appropriate.

• After six weeks, breast feeding began to be supplemented with bottles (Similac formula)due to concerns that the milk volume was becoming insufficient

• Despite the high hormone treatment, the woman's estradiol, prolactin, and progesterone levels at 60-70 days were still below that typical of a pregnant woman in her third trimester

• The study is uncertain as to how useful breast pumping and the use of domperidone actually was.

The study proves that functional lactation can be induced in a transgender women - and the "ground-breaking" approach is extra-ordinarily similar to that first suggested by this website (see below) back in 2001 - including the then unheard of use of domperidone.  The bad news is that however is that despite the patient having unusually good breast development and excellent medical support, she was unable to satisfactorily breast feed the baby for the 4-6 months required until weaning can began.  This is a disappointing precedence for other young transwomen.
 

Many transwomen claim to have succeeded in secreting a milk-like fluid from their breasts, and for most that seems to a key goal achieved.   But in my mind, by far the best objective ever possible is to breast feed your own baby.  Here's some inspiring words I received in 2016 from a 29 year old transwoman, newly married and with an adopted baby:

The happy mother is very probably the same woman featured in the Transgender Health case study described earlier.